For instance, LINC01093 curbed HCC progression by interacting with IGF2BP1 and interfering the binding between IGF2BP1 and GLI1, thus impacting expression of GLI1 downstream molecules associated with HCC progression [14]. This evidence concerns the gene IGF2BP1 and hepatocellular carcinoma.